# Apogee Therapeutics, Inc. (APGE) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Apogee Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/APGE/mda/fy2025/): filed 2026-03-02; accession 0001974640-26-000002 (https://www.sec.gov/Archives/edgar/data/1974640/000197464026000002/apge-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/APGE/mda/fy2024/): filed 2025-03-03; accession 0000950170-25-030385 (https://www.sec.gov/Archives/edgar/data/1974640/000095017025030385/apge-20241231.htm)
- [FY 2023 MD&A](/company/APGE/mda/fy2023/): filed 2024-03-05; accession 0001558370-24-002406 (https://www.sec.gov/Archives/edgar/data/1974640/000155837024002406/apge-20231231x10k.htm)

Back to /company/APGE/